Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension

Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension

The effective therapy for pulmonary arterial hypertension (PAH) with inadequate clinical response is scarce except for lung transplantation when prostacyclin infusion is ineffective. The purpose of this study is to investigate the efficacy and safety of selexipag in addition to the infusion of prost...

Full description

Bibliographic Details
Main Authors: Mizuki Momoi, Takahiro Hiraide, Yoshiki Shinya, Hiromi Momota, Shogo Fukui, Michiyuki Kawakami, Keiichi Fukuda, Masaharu Kataoka
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Drug combinations
Selexipag
Prostacyclin
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007122000144

Internet

http://www.sciencedirect.com/science/article/pii/S2213007122000144

Similar Items